Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model

Journal of Computer Assisted Tomography

Volumn 33, Issue 4, 2009, Pages 626-630

  Vossen, Josephina A ^a   Buijs, Manon ^a   Geschwind, Jean Francois H ^a   Liapi, Eleni ^a   Prieto Ventura, Veronica ^a   Lee, Kwang Hun ^a   Bluemke, David A ^b   Kamel, Ihab R ^c  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Russell H Morgan Department of Radiology and Radiological Science   (United States)

Author keywords

Diffusion weighted MRI; Gd EOB DTPA; HCC; Liver cancer; Tumor necrosis; Tumor size; VX2

Indexed keywords

MAGNETISM; PATHOLOGY; RESONANCE; SCANNING; SURFACE DIFFUSION; TUMORS;

APPARENT DIFFUSION COEFFICIENT; CONTRAST-ENHANCED; DIFFUSION-WEIGHTED MAGNETIC RESONANCE; DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING; GD-EOB-DTPA; HCC; LIVER CANCERS; TUMOR NECROSIS; TUMOR SIZE; VX2;

MAGNETIC RESONANCE IMAGING;

GADOXETIC ACID; PENTETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; HISTOLOGY; LIVER TUMOR; MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RABBIT; THREE DIMENSIONAL IMAGING; TUMOR MODEL; TUMOR NECROSIS; TUMOR VOLUME;

EID: 68949144862     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181953df3     Document Type: Article

References (24)

1. Vossen JA, Buijs M, Kamel IR. Assessment of tumor response on MR imaging after locoregional therapy. Tech Vasc Interv Radiol. 2006;9:125Y132.
2. Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168:497Y505.
3. Benveniste H, Hedlund LW, Johnson GA. Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke. 1992;23:746Y754.
4. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology. 2000;217:331Y345.
5. Buijs M, Kamel IR, Vossen JA, et al. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol. 2007; 18:957Y963.
6. Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology. 2003;226:71Y78.
7. Deng J, Rhee TK, Sato KT, et al. In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol. 2006;41:410Y414.
8. Deng J, Virmani S, Young J, et al. Diffusion-weighted PROPELLER MRI for quantitative assessment of liver tumor necrotic fraction and viable tumor volume in VX2 rabbits. J Magn Reson Imaging. 2008;27:1069Y1076.
9. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology. 1995;195:785Y792.
10. Reimer P, Rummeny EJ, Shamsi K, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology. 1996;199:177Y183.
11. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology. 2004;230:266Y275.
12. Tsuda N, Kato N, Murayama C, et al. Potential for differential diagnosis with gadolinium-ethoxybenzyl-Ydiethylenetriamine pentaacetic acidenhanced magnetic resonance imaging in experimental hepatic tumors. Invest Radiol. 2004;39:80Y88.
13. Zizka J, Klzo L, Ferda J, et al. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol. Eur J Radiol. 2007;62:186Y191.
14. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000;214:761Y768.
15. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734Y1739.
16. Yan K, Chen MH, Yang W, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol. 2008;67:336Y347.
17. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421Y430.
18. Halavaara J, Breuer J, Ayuso C, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CTVa multicenter trial. J Comput Assist Tomogr. 2006;30:345Y354.
19. Saito K, Kotake F, Ito N, et al. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci. 2005;4:1Y9.
20. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology. 2006;239:122Y130.
21. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol. 2008;18:477Y485.
22. Kamel IR, Reyes DK, Liapi E, et al. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2007; 18:49Y56.
23. Mejia GA, Gomez MA, Serrano J, et al. Correlation between the radiologic and histologic size of hepatocellular carcinoma in patients eligible for liver transplantation. Transplant Proc. 2006;38:1394Y1395.
24. Geschwind JF, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol. 2000;11:1245Y1255.